ADPT - Adaptive Biotechnologies announces conclusion of strategic review expects Q1 revenue between $41M and $43M April, 02 2024 04:21 PM Adaptive Biotechnologies Corporation 2024-04-02 16:21:13 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: A Post Earnings Assessment Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M Adaptive Biotechnologies Q4 2023 Earnings Preview For further details see: Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M